Bacterial infections in immunosuppressed patients: diagnosis and management.
D001419:Bacteria / Q000302:isolation & purification*; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D004338:Drug Combinations; D004926:Escherichia coli / Q000302:isolation & purification; D005334:Fever / Q000209:etiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007239:Infections / Q000382:microbiology*; D007612:Kanamycin / Q000627:therapeutic use; D007709:Klebsiella / Q000302:isolation & purification; D008712:Methicillin / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D011113:Polymyxins / Q000627:therapeutic use; D011511:Proteus / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification
D004338:Drug Combinations; D005839:Gentamicins; D007166:Immunosuppressive Agents; D011113:Polymyxins; D007612:Kanamycin; D002228:Carbenicillin; D008712:Methicillin; D002512:Cephalothin; D003091:Colistin